{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2877, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "other", "function": "present_framework", "notes": "The slide uses a standard clinical trial flow diagram (CONSORT-style).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/18", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide presents clinical trial baseline data for three cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/19", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "other", "function": "analyze_data", "notes": "Clinical trial data visualization (Kaplan-Meier plot).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/20", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "comparison_table", "function": "analyze_data", "notes": "Includes a landmark analysis at 9 months for hazard ratios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/21", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "Clinical trial data presentation showing PFS, HR, and TTP metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/22", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "comparison_table", "function": "analyze_data", "notes": "Clinical trial safety data comparing combination therapy vs monotherapy vs standard of care.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/23", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays both 'All grades' and 'Grade ≥3' adverse events for specific medical conditions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/24", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/25", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 9, "beatId": "5bf1753c-e4a0-4e18-b568-73af9c0043f2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents data and results for Imfinzi TOPAZ-1 and HIMALAYA, demonstrating their effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized silhouette of a person with an internal biological/molecular visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/26", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "before_after", "function": "frame_problem", "notes": "Uses a before-after framing to contrast the status quo (problem) with the new clinical solution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/27", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-27", "loopMatches": [ { "to": 27, "from": 27, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a8de0661-f386-49b5-a803-c3d99bc10bab", "evidence": "The deck presents TOPAZ-1 as a potential game-changer in GI cancers", "position": 0, "objective": "Highlight the potential of TOPAZ-1 to become the first-ever IO therapy for first-line, advanced biliary tract cancer patients", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 27, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "7271ea17-f681-46af-8e4d-590555fd889c", "evidence": "The deck presents HIMALAYA as an innovative IO regimen", "position": 1, "objective": "Show the potential of HIMALAYA to deliver survival benefit to patients with advanced, unresectable hepatocellular carcinoma", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a three-column layout to contrast the unmet need, the treatment mechanism, and the clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/28", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-28", "loopMatches": [ { "to": 28, "from": 27, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "7271ea17-f681-46af-8e4d-590555fd889c", "evidence": "The deck presents HIMALAYA as an innovative IO regimen", "position": 1, "objective": "Show the potential of HIMALAYA to deliver survival benefit to patients with advanced, unresectable hepatocellular carcinoma", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized silhouette of a human figure with internal biological/molecular imagery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/29", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "thesis_headline", "function": "size_opportunity", "notes": "The chart uses a bar chart for existing presence and a stacked bar for GI cancer segments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/30", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a split-layout to contrast established late-stage assets (Imfinzi, Enhertu) with early-stage pipeline candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/31", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized silhouette of a person with biological/molecular imagery inside, suggesting a life sciences or medical context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/32", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 26, "beatId": "b07cebc3-7a8b-44be-bf05-017bb65452c0", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a discussion of the commercial opportunity and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/33", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/34", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/35", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart displays hazard ratios with 95% confidence intervals for different demographic and clinical categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/36", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide includes a technical explanation of the TAP score methodology using the Ventana PD-L1 (SP263) Assay.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/37", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/38", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/39", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "appendix_data", "function": "analyze_data", "notes": "The plot visualizes subgroup analysis for a clinical trial, indicating treatment efficacy across different patient demographics and clinical characteristics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/40", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "comparison_table", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/41", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f579-76ad-bea5-b34da2c83a75", "docSlug": "563487226462eb4ab63630eb9b74a5cf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f579-76ad-bea5-b34da2c83a75/42", "deckHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75", "deckAnchorHref": "/decks/019de071-f579-76ad-bea5-b34da2c83a75#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/88q19cR4UF3F7kfLG2b0fzXIv4Wf8KEDOPyzlKp3Lis/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xNWViMmYwZjgzOTQzZWQ2MTI2MGJhY2Q3NWFkYjc3OS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/1", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/m7RYmJHidV8YfNtHrptvQ6ixaYUdpqSTrn7dGABYBF4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xNWViMmYwZjgzOTQzZWQ2MTI2MGJhY2Q3NWFkYjc3OS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/cmvZswXHy68udc-z-TlB5L4ZxpD0xLschVnS7TFRQjo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xNWViMmYwZjgzOTQzZWQ2MTI2MGJhY2Q3NWFkYjc3OS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/E7MXqWwsL3EXxdkUPZEKRclz3s23StCk5Mglp_Ypyo4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xNWViMmYwZjgzOTQzZWQ2MTI2MGJhY2Q3NWFkYjc3OS9wMDAxLnBuZw" }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/2", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/3", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a numbered list format to highlight key strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/4", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a highlighted row for RL-007 and a section for equity interests.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/5", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/6", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/7", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/8", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_messages", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/9", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "d65304e5-46fb-449e-a9cb-edbf18724027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 9-14 highlight the problem of CIAS, its economic burden, and impact on patients' lives", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses icons to represent three key negative outcomes for the patient population.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/10", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-10", "loopMatches": [ { "to": 14, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "11903d2a-4ef2-4df0-880a-cf84dcbfd9e7", "evidence": "Slides 10-14 highlight the economic burden and impact of CIAS on patients' lives, implying the cost of inaction", "position": 0, "objective": "What is the cost of inaction in addressing CIAS?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "d65304e5-46fb-449e-a9cb-edbf18724027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 9-14 highlight the problem of CIAS, its economic burden, and impact on patients' lives", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a citation to support the data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/11", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-11", "loopMatches": [ { "to": 14, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "11903d2a-4ef2-4df0-880a-cf84dcbfd9e7", "evidence": "Slides 10-14 highlight the economic burden and impact of CIAS on patients' lives, implying the cost of inaction", "position": 0, "objective": "What is the cost of inaction in addressing CIAS?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "d65304e5-46fb-449e-a9cb-edbf18724027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 9-14 highlight the problem of CIAS, its economic burden, and impact on patients' lives", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "comparison_table", "function": "analyze_data", "notes": "Data source: Keefe et al, Schiz Res, 2011.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/12", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-12", "loopMatches": [ { "to": 14, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "11903d2a-4ef2-4df0-880a-cf84dcbfd9e7", "evidence": "Slides 10-14 highlight the economic burden and impact of CIAS on patients' lives, implying the cost of inaction", "position": 0, "objective": "What is the cost of inaction in addressing CIAS?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "d65304e5-46fb-449e-a9cb-edbf18724027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 9-14 highlight the problem of CIAS, its economic burden, and impact on patients' lives", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "thesis_headline", "function": "diagnose_problem", "notes": "The slide uses a causal chain diagram to link neurocognitive deficits to functional outcomes and a bar chart to show correlation strength.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/13", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-13", "loopMatches": [ { "to": 14, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "11903d2a-4ef2-4df0-880a-cf84dcbfd9e7", "evidence": "Slides 10-14 highlight the economic burden and impact of CIAS on patients' lives, implying the cost of inaction", "position": 0, "objective": "What is the cost of inaction in addressing CIAS?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "d65304e5-46fb-449e-a9cb-edbf18724027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 9-14 highlight the problem of CIAS, its economic burden, and impact on patients' lives", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The chart uses a broken y-axis between 35 and 100 to accommodate the data distribution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/14", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-14", "loopMatches": [ { "to": 14, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "11903d2a-4ef2-4df0-880a-cf84dcbfd9e7", "evidence": "Slides 10-14 highlight the economic burden and impact of CIAS on patients' lives, implying the cost of inaction", "position": 0, "objective": "What is the cost of inaction in addressing CIAS?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "d65304e5-46fb-449e-a9cb-edbf18724027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 9-14 highlight the problem of CIAS, its economic burden, and impact on patients' lives", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a comparative analysis between cancer and schizophrenia/CIAS to highlight resource allocation disparities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/15", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "ef668d0a-0800-4ad1-a5b6-7beff2661f71", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 15-16 agitate the problem by highlighting the lack of approved treatments and the potential for RL-007 to address this need", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_messages", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/16", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "ef668d0a-0800-4ad1-a5b6-7beff2661f71", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 15-16 agitate the problem by highlighting the lack of approved treatments and the potential for RL-007 to address this need", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_messages", "function": "summarize", "notes": "The slide contrasts specific receptor-targeted programs with a more complex multi-receptor approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/17", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart displays statistical significance markers (*) for specific time points and treatment groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/18", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/19", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/20", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "thesis_headline", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/21", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-21", "loopMatches": [ { "to": 22, "from": 21, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "21a21e3f-dd77-4b2c-ac26-e2f61f7dcb24", "evidence": "Slides 21-22 present RL-007 as a potentially game-changing compound, providing an aha moment for the audience", "position": 1, "objective": "What is the potential of RL-007 to address CIAS?", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_messages", "function": "frame_situation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/22", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-22", "loopMatches": [ { "to": 22, "from": 21, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "21a21e3f-dd77-4b2c-ac26-e2f61f7dcb24", "evidence": "Slides 21-22 present RL-007 as a potentially game-changing compound, providing an aha moment for the audience", "position": 1, "objective": "What is the potential of RL-007 to address CIAS?", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow to map research/clinical stages to specific de-risking milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/23", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/24", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "other", "function": "analyze_data", "notes": "The slide includes a time-series line chart showing fEPSP slope over time and a bar chart showing fEPSP amplitude changes across different treatment conditions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/25", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/26", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "thesis_headline", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/27", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "kpi_overview", "function": "summarize", "notes": "The table maps study types (HV PK, Scopolamine, Peripheral Diabetic Neuropathy) against Phase 1/2 status and key clinical endpoints (Safety/PK, Target Engaged, Biphasic).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/28", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "7effda0b-3140-4201-ba8c-40b7efb15914", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 21-28 present RL-007 as a potential solution, highlighting its de-risked profile, positive pre-clinical results, and promising phase 2a data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses red dashed boxes to highlight the 40mg dose performance in both single and 7-day TID dosing scenarios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/29", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes EEG brain mapping, cognitive test results (Continuity of Attention, Delayed Word Recall), and DPNP study data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/30", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/31", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/32", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "other", "function": "present_framework", "notes": "The slide outlines a clinical trial design including screening, in-patient dosing, and follow-up phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/33", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table uses directional arrows to indicate the direction of change in qEEG endpoints across different cohorts and brain regions (F, C, T, P, O).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/34", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-f648-72d0-9c84-3373768bf908", "docSlug": "15eb2f0f83943ed61260bacd75adb779", "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide presents clinical trial data comparing ERP responses (MMN and P300b) across different dose levels of RL-007.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/35", "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908", "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }